SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 82 filers reported holding SURFACE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,227,942 | -68.0% | 1,412,077 | -74.3% | 0.01% | -69.2% |
Q1 2023 | $3,840,707 | -15.9% | 5,496,146 | -1.3% | 0.03% | -35.0% |
Q4 2022 | $4,565,124 | -27.3% | 5,567,224 | -7.8% | 0.04% | -9.1% |
Q3 2022 | $6,277,000 | -38.9% | 6,035,691 | +8.6% | 0.04% | -27.9% |
Q2 2022 | $10,281,000 | -34.6% | 5,557,382 | +4.0% | 0.06% | -7.6% |
Q1 2022 | $15,709,000 | -38.3% | 5,343,116 | +0.3% | 0.07% | -14.3% |
Q4 2021 | $25,459,000 | -27.2% | 5,326,127 | +15.3% | 0.08% | -8.3% |
Q3 2021 | $34,961,000 | +4.6% | 4,618,354 | +3.1% | 0.08% | +35.5% |
Q2 2021 | $33,410,000 | +5.3% | 4,478,546 | +10.1% | 0.06% | -1.6% |
Q1 2021 | $31,740,000 | +35.1% | 4,069,255 | +60.1% | 0.06% | 0.0% |
Q4 2020 | $23,492,000 | +649.8% | 2,542,391 | +459.9% | 0.06% | +231.6% |
Q3 2020 | $3,133,000 | – | 454,069 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |